Evidence map›Paper›PMID 37930665›Full record

ArticleTranslational vision science & technology2023

Correlation of Aqueous, Vitreous, and Serum Protein Levels in Patients With Retinal Diseases.

Sabine Wilson, Juliane Siebourg-Polster, Bjoern Titz, Zhiwen Jiang, Francois Bartolo, Vincent Lavergne, Javier Gayán, Justus G Garweg, Sascha Fauser, Andreas Dieckmann

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sabine WilsonRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Juliane Siebourg-PolsterRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Bjoern TitzRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Zhiwen JiangRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Francois BartoloRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Vincent LavergneRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Javier GayánRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Justus G GarwegBerner Augenklinik, Bern, Switzerland.
Sascha FauserRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Andreas DieckmannRoche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Roche (Switzerland) · CHBerner Augenklinik am Lindenhofspital · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To further establish aqueous humor (AH) as a clinically suitable source of protein biomarkers in retinal diseases by evaluating the correlation of a large panel of proteins between AH, vitreous humor (VH), and serum (SE). Methods: We enrolled 60 subjects (eyes) with various non-infectious retinal diseases. AH, VH, and SE proteins were analyzed using the Olink Target 96 platform (1196 protein assays in total). We compared these three matrices in terms of quantification overlap, principal component analysis, and correlation. Results: In the AH, VH, and SE samples, 841, 917, and 1133 proteins, respectively, were consistently quantified above the limit of detection in more than 30% of patients. AH and VH shared 812 of these proteins. AH and VH samples overlapped along principal component 1, but SE samples were distinct. We identified 490 proteins with significant (false discovery rate [FDR]-adjusted P < 0.05) and relevant correlations (correlation coefficient > 0.5) between AH and VH, compared to only 33 and 40 proteins for VH and SE and for AH and SE, respectively. Conclusions: Due to a close correlation between protein concentrations in the AH and VH and a clear difference from the SE, AH has the potential to serve as a substitute for VH and may hold significance in identifying protein biomarkers and novel targets related to retinal diseases. Translational Relevance: This study further supports AH as a clinically suitable source of protein biomarkers in retinal diseases. In addition, the identified AH and VH correlations can inform the selection of protein biomarker candidates in future translational research.

Indexed as

Blood ProteinsRetinal DiseasesAqueous HumorBiomarkersHumansRetinaBiomarkersBlood Proteins

Identifiers

PMID37930665
PMCPMC10629536
OpenAlexW4388424034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.